Summit Keynote Speaker John E. Anderson, MD, The First Clinic, addressed clinicians in the audience on the impact cardiometabolic risk - diabetes, hypertension, dyslipidemia, and obesity - is having on the...
In this video, Phil Lempert discusses the recent US Food and Drug Administration approval of a new chronic weight management medication for adults with obesity or overweight.
James Matera, DO, FACOI, is a practicing nephrologist at Nephrology Hypertension Associates of Central New Jersey and co-director of Physician Integration at CentraState Medical Center in Freehold, NJ....
In this video, Diane Mould, PhD, from Projections Research, discusses the important role of monoclonal antibodies in the management of inflammatory diseases.
